Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0293 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0139 | 0.3972 | 0.5 |
Brugia malayi | endochitinase | 0.0098 | 0.2365 | 0.2052 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0293 | 1 | 0.5 |
Onchocerca volvulus | 0.0139 | 0.3972 | 1 | |
Toxoplasma gondii | hypothetical protein | 0.0139 | 0.3972 | 0.5 |
Loa Loa (eye worm) | chitinase I | 0.0088 | 0.195 | 0.2004 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0293 | 1 | 1 |
Brugia malayi | Hepatocellular carcinoma-associated antigen 59 family protein | 0.0139 | 0.3972 | 1 |
Loa Loa (eye worm) | cuticular endochitinase | 0.0088 | 0.195 | 0.2004 |
Leishmania major | chitinase | 0.0088 | 0.195 | 0.5 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0139 | 0.3972 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.3972 | 1 |
Onchocerca volvulus | Putative endochitinase | 0.0098 | 0.2365 | 0.2052 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0293 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.3972 | 1 |
Brugia malayi | Endochitinase | 0.0098 | 0.2365 | 0.2052 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0293 | 1 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0293 | 1 | 1 |
Onchocerca volvulus | Putative endochitinase | 0.0098 | 0.2365 | 0.2052 |
Onchocerca volvulus | 0.0139 | 0.3972 | 1 | |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0139 | 0.3972 | 0.5 |
Entamoeba histolytica | chitinase, putative | 0.0088 | 0.195 | 1 |
Onchocerca volvulus | Putative endochitinase | 0.0098 | 0.2365 | 0.2052 |
Loa Loa (eye worm) | microfilarial chitinase | 0.0085 | 0.1858 | 0.1641 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0293 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.